nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—PTGS2—Risedronate—Paget's disease of bone	0.487	1	CbGbCtD
Thalidomide—Menadione—BGLAP—Paget's disease of bone	0.0125	1	CrCbGaD
Thalidomide—NFKB1—NF-kB is activated and signals survival—SQSTM1—Paget's disease of bone	0.00581	0.0661	CbGpPWpGaD
Thalidomide—NFKB1—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00547	0.0622	CbGpPWpGaD
Thalidomide—NFKB1—p75NTR signals via NF-kB—SQSTM1—Paget's disease of bone	0.00492	0.056	CbGpPWpGaD
Thalidomide—TNF—Cytokines and Inflammatory Response—CSF1—Paget's disease of bone	0.00363	0.0413	CbGpPWpGaD
Thalidomide—NFKB1—EPO signaling pathway—INPP5D—Paget's disease of bone	0.00316	0.0359	CbGpPWpGaD
Thalidomide—TNF—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.0028	0.0318	CbGpPWpGaD
Thalidomide—NFKB1—IL1-mediated signaling events—SQSTM1—Paget's disease of bone	0.00269	0.0306	CbGpPWpGaD
Thalidomide—NFKB1—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.00259	0.0294	CbGpPWpGaD
Thalidomide—NFKB1—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00238	0.0271	CbGpPWpGaD
Thalidomide—NFKB1—Interleukin-1 signaling—SQSTM1—Paget's disease of bone	0.00237	0.0269	CbGpPWpGaD
Thalidomide—NFKB1—Folate Metabolism—CSF1—Paget's disease of bone	0.00233	0.0265	CbGpPWpGaD
Thalidomide—NFKB1—TNF receptor signaling pathway —SQSTM1—Paget's disease of bone	0.00212	0.0241	CbGpPWpGaD
Thalidomide—NFKB1—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.00208	0.0236	CbGpPWpGaD
Thalidomide—FGFR2—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00205	0.0234	CbGpPWpGaD
Thalidomide—NFKB1—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.00199	0.0226	CbGpPWpGaD
Thalidomide—NFKB1—TCR signaling—INPP5D—Paget's disease of bone	0.00193	0.022	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00189	0.0215	CbGpPWpGaD
Thalidomide—NFKB1—Fc-epsilon receptor I signaling in mast cells—INPP5D—Paget's disease of bone	0.00188	0.0214	CbGpPWpGaD
Thalidomide—NFKB1—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.00183	0.0209	CbGpPWpGaD
Thalidomide—NFKB1—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.00183	0.0209	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—CSF1—Paget's disease of bone	0.00178	0.0202	CbGpPWpGaD
Thalidomide—NFKB1—BCR signaling pathway—INPP5D—Paget's disease of bone	0.00175	0.0199	CbGpPWpGaD
Thalidomide—TNF—TNF receptor signaling pathway —SQSTM1—Paget's disease of bone	0.00161	0.0183	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis Modulation and Signaling—TNFRSF11B—Paget's disease of bone	0.00159	0.0181	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.00155	0.0176	CbGpPWpGaD
Thalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—Paget's disease of bone	0.00144	0.0164	CbGpPWpGaD
Thalidomide—NFKB1—p75 NTR receptor-mediated signalling—SQSTM1—Paget's disease of bone	0.00133	0.0152	CbGpPWpGaD
Thalidomide—NFKB1—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.0013	0.0148	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.00119	0.0136	CbGpPWpGaD
Thalidomide—FGFR2—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.00108	0.0123	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.00107	0.0122	CbGpPWpGaD
Thalidomide—NFKB1—BDNF signaling pathway—ALPL—Paget's disease of bone	0.00107	0.0121	CbGpPWpGaD
Thalidomide—FGFR2—skull—Paget's disease of bone	0.00104	0.467	CbGeAlD
Thalidomide—NFKB1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.000945	0.0108	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—VCP—Paget's disease of bone	0.000895	0.0102	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000873	0.00994	CbGpPWpGaD
Thalidomide—NFKB1—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000849	0.00966	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000783	0.00891	CbGpPWpGaD
Thalidomide—NFKB1—Myometrial Relaxation and Contraction Pathways—CALCA—Paget's disease of bone	0.000777	0.00884	CbGpPWpGaD
Thalidomide—Agranulocytosis—Pamidronate—Paget's disease of bone	0.000702	0.00171	CcSEcCtD
Thalidomide—Urinary tract disorder—Risedronate—Paget's disease of bone	0.000702	0.00171	CcSEcCtD
Thalidomide—Weight increased—Zoledronate—Paget's disease of bone	0.000701	0.00171	CcSEcCtD
Thalidomide—Oedema peripheral—Risedronate—Paget's disease of bone	0.0007	0.0017	CcSEcCtD
Thalidomide—Weight decreased—Zoledronate—Paget's disease of bone	0.000697	0.0017	CcSEcCtD
Thalidomide—Urethral disorder—Risedronate—Paget's disease of bone	0.000696	0.0017	CcSEcCtD
Thalidomide—Malaise—Alendronate—Paget's disease of bone	0.000695	0.00169	CcSEcCtD
Thalidomide—Vertigo—Alendronate—Paget's disease of bone	0.000692	0.00169	CcSEcCtD
Thalidomide—Infestation NOS—Zoledronate—Paget's disease of bone	0.000687	0.00167	CcSEcCtD
Thalidomide—Infestation—Zoledronate—Paget's disease of bone	0.000687	0.00167	CcSEcCtD
Thalidomide—Depression—Zoledronate—Paget's disease of bone	0.000685	0.00167	CcSEcCtD
Thalidomide—Rhinitis—Pamidronate—Paget's disease of bone	0.000677	0.00165	CcSEcCtD
Thalidomide—Renal failure—Zoledronate—Paget's disease of bone	0.000675	0.00165	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000673	0.00164	CcSEcCtD
Thalidomide—Stomatitis—Zoledronate—Paget's disease of bone	0.00067	0.00163	CcSEcCtD
Thalidomide—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000668	0.00163	CcSEcCtD
Thalidomide—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000667	0.00162	CcSEcCtD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000665	0.00757	CbGpPWpGaD
Thalidomide—Eye disorder—Risedronate—Paget's disease of bone	0.000664	0.00162	CcSEcCtD
Thalidomide—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000663	0.00161	CcSEcCtD
Thalidomide—Tinnitus—Risedronate—Paget's disease of bone	0.000662	0.00161	CcSEcCtD
Thalidomide—Urethral disorder—Pamidronate—Paget's disease of bone	0.000662	0.00161	CcSEcCtD
Thalidomide—Cardiac disorder—Risedronate—Paget's disease of bone	0.000659	0.00161	CcSEcCtD
Thalidomide—Myalgia—Alendronate—Paget's disease of bone	0.000656	0.0016	CcSEcCtD
Thalidomide—Chest pain—Alendronate—Paget's disease of bone	0.000656	0.0016	CcSEcCtD
Thalidomide—Haematuria—Zoledronate—Paget's disease of bone	0.000655	0.0016	CcSEcCtD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000653	0.00742	CbGpPWpGaD
Thalidomide—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00065	0.00158	CcSEcCtD
Thalidomide—Discomfort—Alendronate—Paget's disease of bone	0.000648	0.00158	CcSEcCtD
Thalidomide—Angiopathy—Risedronate—Paget's disease of bone	0.000644	0.00157	CcSEcCtD
Thalidomide—Immune system disorder—Risedronate—Paget's disease of bone	0.000642	0.00156	CcSEcCtD
Thalidomide—Agranulocytosis—Zoledronate—Paget's disease of bone	0.000641	0.00156	CcSEcCtD
Thalidomide—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00064	0.00156	CcSEcCtD
Thalidomide—Arrhythmia—Risedronate—Paget's disease of bone	0.000635	0.00155	CcSEcCtD
Thalidomide—Constipation—Etidronic acid—Paget's disease of bone	0.000631	0.00154	CcSEcCtD
Thalidomide—Eye disorder—Pamidronate—Paget's disease of bone	0.000631	0.00154	CcSEcCtD
Thalidomide—Bradycardia—Zoledronate—Paget's disease of bone	0.000628	0.00153	CcSEcCtD
Thalidomide—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000627	0.00153	CcSEcCtD
Thalidomide—Infection—Alendronate—Paget's disease of bone	0.000625	0.00152	CcSEcCtD
Thalidomide—Mental disorder—Risedronate—Paget's disease of bone	0.000622	0.00152	CcSEcCtD
Thalidomide—Malnutrition—Risedronate—Paget's disease of bone	0.000618	0.00151	CcSEcCtD
Thalidomide—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.000614	0.00149	CcSEcCtD
Thalidomide—Angiopathy—Pamidronate—Paget's disease of bone	0.000613	0.00149	CcSEcCtD
Thalidomide—Immune system disorder—Pamidronate—Paget's disease of bone	0.00061	0.00149	CcSEcCtD
Thalidomide—Flatulence—Risedronate—Paget's disease of bone	0.000609	0.00148	CcSEcCtD
Thalidomide—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000609	0.00148	CcSEcCtD
Thalidomide—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000609	0.00148	CcSEcCtD
Thalidomide—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000608	0.00148	CcSEcCtD
Thalidomide—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000608	0.00148	CcSEcCtD
Thalidomide—Chills—Pamidronate—Paget's disease of bone	0.000606	0.00148	CcSEcCtD
Thalidomide—Urethral disorder—Zoledronate—Paget's disease of bone	0.000605	0.00147	CcSEcCtD
Thalidomide—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.000604	0.00147	CcSEcCtD
Thalidomide—Back pain—Risedronate—Paget's disease of bone	0.000598	0.00146	CcSEcCtD
Thalidomide—Alopecia—Pamidronate—Paget's disease of bone	0.000597	0.00145	CcSEcCtD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000597	0.00679	CbGpPWpGaD
Thalidomide—Muscle spasms—Risedronate—Paget's disease of bone	0.000595	0.00145	CcSEcCtD
Thalidomide—Malnutrition—Pamidronate—Paget's disease of bone	0.000588	0.00143	CcSEcCtD
Thalidomide—Urticaria—Etidronic acid—Paget's disease of bone	0.000586	0.00143	CcSEcCtD
Thalidomide—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000584	0.00142	CcSEcCtD
Thalidomide—Tension—Pamidronate—Paget's disease of bone	0.000577	0.00141	CcSEcCtD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000577	0.00656	CbGpPWpGaD
Thalidomide—Eye disorder—Zoledronate—Paget's disease of bone	0.000576	0.0014	CcSEcCtD
Thalidomide—Dysgeusia—Pamidronate—Paget's disease of bone	0.000576	0.0014	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000573	0.0014	CcSEcCtD
Thalidomide—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000572	0.00139	CcSEcCtD
Thalidomide—Anaemia—Risedronate—Paget's disease of bone	0.000572	0.00139	CcSEcCtD
Thalidomide—Nervousness—Pamidronate—Paget's disease of bone	0.000571	0.00139	CcSEcCtD
Thalidomide—Back pain—Pamidronate—Paget's disease of bone	0.000569	0.00139	CcSEcCtD
Thalidomide—Muscle spasms—Pamidronate—Paget's disease of bone	0.000565	0.00138	CcSEcCtD
Thalidomide—Angioedema—Risedronate—Paget's disease of bone	0.000565	0.00138	CcSEcCtD
Thalidomide—Angiopathy—Zoledronate—Paget's disease of bone	0.00056	0.00136	CcSEcCtD
Thalidomide—Immune system disorder—Zoledronate—Paget's disease of bone	0.000557	0.00136	CcSEcCtD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000556	0.00633	CbGpPWpGaD
Thalidomide—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000556	0.00135	CcSEcCtD
Thalidomide—Vertigo—Risedronate—Paget's disease of bone	0.000556	0.00135	CcSEcCtD
Thalidomide—Syncope—Risedronate—Paget's disease of bone	0.000555	0.00135	CcSEcCtD
Thalidomide—Dyspepsia—Alendronate—Paget's disease of bone	0.000554	0.00135	CcSEcCtD
Thalidomide—Chills—Zoledronate—Paget's disease of bone	0.000553	0.00135	CcSEcCtD
Thalidomide—Arrhythmia—Zoledronate—Paget's disease of bone	0.000551	0.00134	CcSEcCtD
Thalidomide—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.000545	0.00133	CcSEcCtD
Thalidomide—Alopecia—Zoledronate—Paget's disease of bone	0.000545	0.00133	CcSEcCtD
Thalidomide—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.000544	0.00132	CcSEcCtD
Thalidomide—Loss of consciousness—Risedronate—Paget's disease of bone	0.000543	0.00132	CcSEcCtD
Thalidomide—Anaemia—Pamidronate—Paget's disease of bone	0.000543	0.00132	CcSEcCtD
Thalidomide—Mental disorder—Zoledronate—Paget's disease of bone	0.00054	0.00132	CcSEcCtD
Thalidomide—Agitation—Pamidronate—Paget's disease of bone	0.00054	0.00132	CcSEcCtD
Thalidomide—Cough—Risedronate—Paget's disease of bone	0.00054	0.00131	CcSEcCtD
Thalidomide—Constipation—Alendronate—Paget's disease of bone	0.000538	0.00131	CcSEcCtD
Thalidomide—Pain—Alendronate—Paget's disease of bone	0.000538	0.00131	CcSEcCtD
Thalidomide—Angioedema—Pamidronate—Paget's disease of bone	0.000537	0.00131	CcSEcCtD
Thalidomide—Malnutrition—Zoledronate—Paget's disease of bone	0.000537	0.00131	CcSEcCtD
Thalidomide—Hypertension—Risedronate—Paget's disease of bone	0.000534	0.0013	CcSEcCtD
Thalidomide—Malaise—Pamidronate—Paget's disease of bone	0.00053	0.00129	CcSEcCtD
Thalidomide—Syncope—Pamidronate—Paget's disease of bone	0.000527	0.00128	CcSEcCtD
Thalidomide—Chest pain—Risedronate—Paget's disease of bone	0.000526	0.00128	CcSEcCtD
Thalidomide—Myalgia—Risedronate—Paget's disease of bone	0.000526	0.00128	CcSEcCtD
Thalidomide—Arthralgia—Risedronate—Paget's disease of bone	0.000526	0.00128	CcSEcCtD
Thalidomide—Leukopenia—Pamidronate—Paget's disease of bone	0.000526	0.00128	CcSEcCtD
Thalidomide—Dysgeusia—Zoledronate—Paget's disease of bone	0.000526	0.00128	CcSEcCtD
Thalidomide—Anxiety—Risedronate—Paget's disease of bone	0.000525	0.00128	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.000523	0.00127	CcSEcCtD
Thalidomide—Pruritus—Etidronic acid—Paget's disease of bone	0.000522	0.00127	CcSEcCtD
Thalidomide—Back pain—Zoledronate—Paget's disease of bone	0.000519	0.00127	CcSEcCtD
Thalidomide—Feeling abnormal—Alendronate—Paget's disease of bone	0.000518	0.00126	CcSEcCtD
Thalidomide—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000517	0.00126	CcSEcCtD
Thalidomide—Muscle spasms—Zoledronate—Paget's disease of bone	0.000516	0.00126	CcSEcCtD
Thalidomide—Dry mouth—Risedronate—Paget's disease of bone	0.000515	0.00125	CcSEcCtD
Thalidomide—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000514	0.00125	CcSEcCtD
Thalidomide—Cough—Pamidronate—Paget's disease of bone	0.000513	0.00125	CcSEcCtD
Thalidomide—Convulsion—Pamidronate—Paget's disease of bone	0.000509	0.00124	CcSEcCtD
Thalidomide—Hypertension—Pamidronate—Paget's disease of bone	0.000508	0.00124	CcSEcCtD
Thalidomide—Vision blurred—Zoledronate—Paget's disease of bone	0.000506	0.00123	CcSEcCtD
Thalidomide—Diarrhoea—Etidronic acid—Paget's disease of bone	0.000505	0.00123	CcSEcCtD
Thalidomide—Tremor—Zoledronate—Paget's disease of bone	0.000503	0.00123	CcSEcCtD
Thalidomide—Infection—Risedronate—Paget's disease of bone	0.000501	0.00122	CcSEcCtD
Thalidomide—Myalgia—Pamidronate—Paget's disease of bone	0.0005	0.00122	CcSEcCtD
Thalidomide—Arthralgia—Pamidronate—Paget's disease of bone	0.0005	0.00122	CcSEcCtD
Thalidomide—Urticaria—Alendronate—Paget's disease of bone	0.0005	0.00122	CcSEcCtD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000499	0.00567	CbGpPWpGaD
Thalidomide—Anxiety—Pamidronate—Paget's disease of bone	0.000499	0.00121	CcSEcCtD
Thalidomide—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.000498	0.00121	CcSEcCtD
Thalidomide—Abdominal pain—Alendronate—Paget's disease of bone	0.000497	0.00121	CcSEcCtD
Thalidomide—Body temperature increased—Alendronate—Paget's disease of bone	0.000497	0.00121	CcSEcCtD
Thalidomide—Shock—Risedronate—Paget's disease of bone	0.000497	0.00121	CcSEcCtD
Thalidomide—Anaemia—Zoledronate—Paget's disease of bone	0.000496	0.00121	CcSEcCtD
Thalidomide—Nervous system disorder—Risedronate—Paget's disease of bone	0.000495	0.00121	CcSEcCtD
Thalidomide—Discomfort—Pamidronate—Paget's disease of bone	0.000494	0.0012	CcSEcCtD
Thalidomide—Agitation—Zoledronate—Paget's disease of bone	0.000493	0.0012	CcSEcCtD
Thalidomide—Angioedema—Zoledronate—Paget's disease of bone	0.000491	0.0012	CcSEcCtD
Thalidomide—NFKB1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.00049	0.00558	CbGpPWpGaD
Thalidomide—Skin disorder—Risedronate—Paget's disease of bone	0.00049	0.00119	CcSEcCtD
Thalidomide—Malaise—Zoledronate—Paget's disease of bone	0.000484	0.00118	CcSEcCtD
Thalidomide—Confusional state—Pamidronate—Paget's disease of bone	0.000484	0.00118	CcSEcCtD
Thalidomide—Vertigo—Zoledronate—Paget's disease of bone	0.000482	0.00118	CcSEcCtD
Thalidomide—Syncope—Zoledronate—Paget's disease of bone	0.000482	0.00117	CcSEcCtD
Thalidomide—Leukopenia—Zoledronate—Paget's disease of bone	0.000481	0.00117	CcSEcCtD
Thalidomide—Oedema—Pamidronate—Paget's disease of bone	0.00048	0.00117	CcSEcCtD
Thalidomide—Infection—Pamidronate—Paget's disease of bone	0.000477	0.00116	CcSEcCtD
Thalidomide—Palpitations—Zoledronate—Paget's disease of bone	0.000474	0.00116	CcSEcCtD
Thalidomide—Shock—Pamidronate—Paget's disease of bone	0.000472	0.00115	CcSEcCtD
Thalidomide—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000472	0.00115	CcSEcCtD
Thalidomide—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00047	0.00115	CcSEcCtD
Thalidomide—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00047	0.00114	CcSEcCtD
Thalidomide—Vomiting—Etidronic acid—Paget's disease of bone	0.000469	0.00114	CcSEcCtD
Thalidomide—Cough—Zoledronate—Paget's disease of bone	0.000469	0.00114	CcSEcCtD
Thalidomide—Tachycardia—Pamidronate—Paget's disease of bone	0.000468	0.00114	CcSEcCtD
Thalidomide—Rash—Etidronic acid—Paget's disease of bone	0.000465	0.00113	CcSEcCtD
Thalidomide—FGFR2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000465	0.00529	CbGpPWpGaD
Thalidomide—Convulsion—Zoledronate—Paget's disease of bone	0.000465	0.00113	CcSEcCtD
Thalidomide—Dermatitis—Etidronic acid—Paget's disease of bone	0.000465	0.00113	CcSEcCtD
Thalidomide—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000464	0.00113	CcSEcCtD
Thalidomide—Hypertension—Zoledronate—Paget's disease of bone	0.000464	0.00113	CcSEcCtD
Thalidomide—Hypersensitivity—Alendronate—Paget's disease of bone	0.000463	0.00113	CcSEcCtD
Thalidomide—Headache—Etidronic acid—Paget's disease of bone	0.000462	0.00113	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00046	0.00112	CcSEcCtD
Thalidomide—Anorexia—Pamidronate—Paget's disease of bone	0.000457	0.00111	CcSEcCtD
Thalidomide—Arthralgia—Zoledronate—Paget's disease of bone	0.000457	0.00111	CcSEcCtD
Thalidomide—Chest pain—Zoledronate—Paget's disease of bone	0.000457	0.00111	CcSEcCtD
Thalidomide—Myalgia—Zoledronate—Paget's disease of bone	0.000457	0.00111	CcSEcCtD
Thalidomide—Insomnia—Risedronate—Paget's disease of bone	0.000456	0.00111	CcSEcCtD
Thalidomide—Anxiety—Zoledronate—Paget's disease of bone	0.000456	0.00111	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000454	0.00111	CcSEcCtD
Thalidomide—Paraesthesia—Risedronate—Paget's disease of bone	0.000453	0.0011	CcSEcCtD
Thalidomide—Discomfort—Zoledronate—Paget's disease of bone	0.000452	0.0011	CcSEcCtD
Thalidomide—Asthenia—Alendronate—Paget's disease of bone	0.000451	0.0011	CcSEcCtD
Thalidomide—Dyspnoea—Risedronate—Paget's disease of bone	0.00045	0.0011	CcSEcCtD
Thalidomide—Hypotension—Pamidronate—Paget's disease of bone	0.000448	0.00109	CcSEcCtD
Thalidomide—Dry mouth—Zoledronate—Paget's disease of bone	0.000447	0.00109	CcSEcCtD
Thalidomide—Pruritus—Alendronate—Paget's disease of bone	0.000445	0.00108	CcSEcCtD
Thalidomide—Dyspepsia—Risedronate—Paget's disease of bone	0.000444	0.00108	CcSEcCtD
Thalidomide—Confusional state—Zoledronate—Paget's disease of bone	0.000442	0.00108	CcSEcCtD
Thalidomide—Nausea—Etidronic acid—Paget's disease of bone	0.000438	0.00107	CcSEcCtD
Thalidomide—Oedema—Zoledronate—Paget's disease of bone	0.000438	0.00107	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000437	0.00106	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000436	0.00106	CcSEcCtD
Thalidomide—Infection—Zoledronate—Paget's disease of bone	0.000435	0.00106	CcSEcCtD
Thalidomide—Fatigue—Risedronate—Paget's disease of bone	0.000435	0.00106	CcSEcCtD
Thalidomide—Insomnia—Pamidronate—Paget's disease of bone	0.000434	0.00106	CcSEcCtD
Thalidomide—Pain—Risedronate—Paget's disease of bone	0.000432	0.00105	CcSEcCtD
Thalidomide—Constipation—Risedronate—Paget's disease of bone	0.000432	0.00105	CcSEcCtD
Thalidomide—Shock—Zoledronate—Paget's disease of bone	0.000431	0.00105	CcSEcCtD
Thalidomide—Paraesthesia—Pamidronate—Paget's disease of bone	0.000431	0.00105	CcSEcCtD
Thalidomide—Diarrhoea—Alendronate—Paget's disease of bone	0.00043	0.00105	CcSEcCtD
Thalidomide—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00043	0.00105	CcSEcCtD
Thalidomide—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000429	0.00105	CcSEcCtD
Thalidomide—Dyspnoea—Pamidronate—Paget's disease of bone	0.000428	0.00104	CcSEcCtD
Thalidomide—Tachycardia—Zoledronate—Paget's disease of bone	0.000428	0.00104	CcSEcCtD
Thalidomide—Somnolence—Pamidronate—Paget's disease of bone	0.000426	0.00104	CcSEcCtD
Thalidomide—Skin disorder—Zoledronate—Paget's disease of bone	0.000426	0.00104	CcSEcCtD
Thalidomide—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000424	0.00103	CcSEcCtD
Thalidomide—Dyspepsia—Pamidronate—Paget's disease of bone	0.000422	0.00103	CcSEcCtD
Thalidomide—Anorexia—Zoledronate—Paget's disease of bone	0.000418	0.00102	CcSEcCtD
Thalidomide—Decreased appetite—Pamidronate—Paget's disease of bone	0.000417	0.00102	CcSEcCtD
Thalidomide—Dizziness—Alendronate—Paget's disease of bone	0.000416	0.00101	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000414	0.00101	CcSEcCtD
Thalidomide—Fatigue—Pamidronate—Paget's disease of bone	0.000414	0.00101	CcSEcCtD
Thalidomide—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000413	0.00101	CcSEcCtD
Thalidomide—Pain—Pamidronate—Paget's disease of bone	0.00041	0.000999	CcSEcCtD
Thalidomide—Constipation—Pamidronate—Paget's disease of bone	0.00041	0.000999	CcSEcCtD
Thalidomide—Hypotension—Zoledronate—Paget's disease of bone	0.000409	0.000997	CcSEcCtD
Thalidomide—Urticaria—Risedronate—Paget's disease of bone	0.000401	0.000977	CcSEcCtD
Thalidomide—Vomiting—Alendronate—Paget's disease of bone	0.0004	0.000974	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000399	0.000973	CcSEcCtD
Thalidomide—Abdominal pain—Risedronate—Paget's disease of bone	0.000399	0.000972	CcSEcCtD
Thalidomide—Body temperature increased—Risedronate—Paget's disease of bone	0.000399	0.000972	CcSEcCtD
Thalidomide—Rash—Alendronate—Paget's disease of bone	0.000397	0.000966	CcSEcCtD
Thalidomide—Insomnia—Zoledronate—Paget's disease of bone	0.000396	0.000965	CcSEcCtD
Thalidomide—Dermatitis—Alendronate—Paget's disease of bone	0.000396	0.000965	CcSEcCtD
Thalidomide—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000395	0.000963	CcSEcCtD
Thalidomide—Headache—Alendronate—Paget's disease of bone	0.000394	0.00096	CcSEcCtD
Thalidomide—Paraesthesia—Zoledronate—Paget's disease of bone	0.000393	0.000959	CcSEcCtD
Thalidomide—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000392	0.000956	CcSEcCtD
Thalidomide—Dyspnoea—Zoledronate—Paget's disease of bone	0.000391	0.000952	CcSEcCtD
Thalidomide—Somnolence—Zoledronate—Paget's disease of bone	0.00039	0.000949	CcSEcCtD
Thalidomide—Dyspepsia—Zoledronate—Paget's disease of bone	0.000386	0.00094	CcSEcCtD
Thalidomide—Decreased appetite—Zoledronate—Paget's disease of bone	0.000381	0.000928	CcSEcCtD
Thalidomide—Abdominal pain—Pamidronate—Paget's disease of bone	0.000379	0.000924	CcSEcCtD
Thalidomide—Body temperature increased—Pamidronate—Paget's disease of bone	0.000379	0.000924	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000378	0.000922	CcSEcCtD
Thalidomide—Fatigue—Zoledronate—Paget's disease of bone	0.000378	0.00092	CcSEcCtD
Thalidomide—Pain—Zoledronate—Paget's disease of bone	0.000375	0.000913	CcSEcCtD
Thalidomide—Constipation—Zoledronate—Paget's disease of bone	0.000375	0.000913	CcSEcCtD
Thalidomide—Nausea—Alendronate—Paget's disease of bone	0.000374	0.00091	CcSEcCtD
Thalidomide—Hypersensitivity—Risedronate—Paget's disease of bone	0.000372	0.000906	CcSEcCtD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000369	0.0042	CbGpPWpGaD
Thalidomide—Asthenia—Risedronate—Paget's disease of bone	0.000362	0.000882	CcSEcCtD
Thalidomide—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000361	0.00088	CcSEcCtD
Thalidomide—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000358	0.000873	CcSEcCtD
Thalidomide—Pruritus—Risedronate—Paget's disease of bone	0.000357	0.00087	CcSEcCtD
Thalidomide—CYP2C19—urine—Paget's disease of bone	0.000357	0.16	CbGeAlD
Thalidomide—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000353	0.000861	CcSEcCtD
Thalidomide—Urticaria—Zoledronate—Paget's disease of bone	0.000348	0.000848	CcSEcCtD
Thalidomide—Abdominal pain—Zoledronate—Paget's disease of bone	0.000346	0.000844	CcSEcCtD
Thalidomide—Body temperature increased—Zoledronate—Paget's disease of bone	0.000346	0.000844	CcSEcCtD
Thalidomide—Diarrhoea—Risedronate—Paget's disease of bone	0.000345	0.000841	CcSEcCtD
Thalidomide—Asthenia—Pamidronate—Paget's disease of bone	0.000344	0.000838	CcSEcCtD
Thalidomide—Pruritus—Pamidronate—Paget's disease of bone	0.000339	0.000827	CcSEcCtD
Thalidomide—Dizziness—Risedronate—Paget's disease of bone	0.000334	0.000813	CcSEcCtD
Thalidomide—Diarrhoea—Pamidronate—Paget's disease of bone	0.000328	0.0008	CcSEcCtD
Thalidomide—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000323	0.000786	CcSEcCtD
Thalidomide—Vomiting—Risedronate—Paget's disease of bone	0.000321	0.000782	CcSEcCtD
Thalidomide—Rash—Risedronate—Paget's disease of bone	0.000318	0.000775	CcSEcCtD
Thalidomide—Dermatitis—Risedronate—Paget's disease of bone	0.000318	0.000774	CcSEcCtD
Thalidomide—Dizziness—Pamidronate—Paget's disease of bone	0.000317	0.000773	CcSEcCtD
Thalidomide—Headache—Risedronate—Paget's disease of bone	0.000316	0.00077	CcSEcCtD
Thalidomide—Asthenia—Zoledronate—Paget's disease of bone	0.000314	0.000766	CcSEcCtD
Thalidomide—Pruritus—Zoledronate—Paget's disease of bone	0.00031	0.000755	CcSEcCtD
Thalidomide—Vomiting—Pamidronate—Paget's disease of bone	0.000305	0.000743	CcSEcCtD
Thalidomide—Rash—Pamidronate—Paget's disease of bone	0.000302	0.000737	CcSEcCtD
Thalidomide—Dermatitis—Pamidronate—Paget's disease of bone	0.000302	0.000736	CcSEcCtD
Thalidomide—Headache—Pamidronate—Paget's disease of bone	0.000301	0.000732	CcSEcCtD
Thalidomide—Diarrhoea—Zoledronate—Paget's disease of bone	0.0003	0.00073	CcSEcCtD
Thalidomide—Nausea—Risedronate—Paget's disease of bone	0.0003	0.00073	CcSEcCtD
Thalidomide—NFKB1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.0003	0.00341	CbGpPWpGaD
Thalidomide—CYP1A2—urine—Paget's disease of bone	0.000292	0.131	CbGeAlD
Thalidomide—Dizziness—Zoledronate—Paget's disease of bone	0.00029	0.000706	CcSEcCtD
Thalidomide—Nausea—Pamidronate—Paget's disease of bone	0.000285	0.000694	CcSEcCtD
Thalidomide—FGFR2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000284	0.00323	CbGpPWpGaD
Thalidomide—Vomiting—Zoledronate—Paget's disease of bone	0.000279	0.000679	CcSEcCtD
Thalidomide—CYP2C9—urine—Paget's disease of bone	0.000277	0.124	CbGeAlD
Thalidomide—Rash—Zoledronate—Paget's disease of bone	0.000276	0.000673	CcSEcCtD
Thalidomide—Dermatitis—Zoledronate—Paget's disease of bone	0.000276	0.000672	CcSEcCtD
Thalidomide—Headache—Zoledronate—Paget's disease of bone	0.000275	0.000669	CcSEcCtD
Thalidomide—CYP2E1—urine—Paget's disease of bone	0.000262	0.118	CbGeAlD
Thalidomide—Nausea—Zoledronate—Paget's disease of bone	0.00026	0.000634	CcSEcCtD
Thalidomide—FGFR2—Disease—VCP—Paget's disease of bone	0.000244	0.00278	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—NUP205—Paget's disease of bone	0.000213	0.00242	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—NUP205—Paget's disease of bone	0.000202	0.0023	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—PML—Paget's disease of bone	0.000188	0.00214	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000187	0.00213	CbGpPWpGaD
Thalidomide—FGFR2—Disease—NUP205—Paget's disease of bone	0.000187	0.00212	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—INPP5D—Paget's disease of bone	0.000182	0.00207	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—VCP—Paget's disease of bone	0.00018	0.00205	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—PML—Paget's disease of bone	0.000179	0.00203	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—INPP5D—Paget's disease of bone	0.000172	0.00196	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—VCP—Paget's disease of bone	0.000171	0.00195	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—SQSTM1—Paget's disease of bone	0.000163	0.00185	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—SQSTM1—Paget's disease of bone	0.000155	0.00176	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000149	0.00169	CbGpPWpGaD
Thalidomide—FGFR2—Disease—CALCA—Paget's disease of bone	0.000139	0.00158	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000132	0.0015	CbGpPWpGaD
Thalidomide—PTGS2—Disease—VCP—Paget's disease of bone	0.000121	0.00138	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	0.000108	0.00123	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000105	0.0012	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CALCA—Paget's disease of bone	0.000102	0.00116	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SQSTM1—Paget's disease of bone	9.99e-05	0.00114	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	9.85e-05	0.00112	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—NUP205—Paget's disease of bone	9.78e-05	0.00111	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CALCA—Paget's disease of bone	9.71e-05	0.0011	CbGpPWpGaD
Thalidomide—PTGS2—Disease—NUP205—Paget's disease of bone	9.27e-05	0.00105	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	8.41e-05	0.000957	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—INPP5D—Paget's disease of bone	8.34e-05	0.000949	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—NUP205—Paget's disease of bone	7.76e-05	0.000883	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—NUP205—Paget's disease of bone	7.31e-05	0.000831	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—NUP205—Paget's disease of bone	7.29e-05	0.00083	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—NUP205—Paget's disease of bone	6.89e-05	0.000784	CbGpPWpGaD
Thalidomide—PTGS2—Disease—CALCA—Paget's disease of bone	6.88e-05	0.000783	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—INPP5D—Paget's disease of bone	6.62e-05	0.000753	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—INPP5D—Paget's disease of bone	6.23e-05	0.000709	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—INPP5D—Paget's disease of bone	6.22e-05	0.000708	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—INPP5D—Paget's disease of bone	5.88e-05	0.000668	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—NUP205—Paget's disease of bone	5.64e-05	0.000641	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—NUP205—Paget's disease of bone	5.14e-05	0.000585	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—INPP5D—Paget's disease of bone	4.81e-05	0.000547	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—NUP205—Paget's disease of bone	4.39e-05	0.0005	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	4.38e-05	0.000499	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—INPP5D—Paget's disease of bone	3.75e-05	0.000426	CbGpPWpGaD
